کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3943521 1254118 2007 8 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Prevention of adhesion formation after radical hysterectomy using a sodium hyaluronate–carboxymethylcellulose (HA–CMC) barrier: A cost-effectiveness analysis
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی زنان، زایمان و بهداشت زنان
پیش نمایش صفحه اول مقاله
Prevention of adhesion formation after radical hysterectomy using a sodium hyaluronate–carboxymethylcellulose (HA–CMC) barrier: A cost-effectiveness analysis
چکیده انگلیسی

Objective.To evaluate the cost-effectiveness of an adhesion prevention strategy compared to routine care, in which no adhesion prevention measures are taken, through a decision analysis model in the clinical setting of patients undergoing radical hysterectomy and pelvic lymphadenectomy for Stage IB cervical cancer.Methods.A decision analysis model compared two strategies to manage the risk of adhesion-related morbidity following radical hysterectomy for Stage IB cervical cancer: (1) routine care with no adhesion prevention measures, and (2) the intervention strategy with a HA–CMC anti-adhesion barrier. The cost-effectiveness of each strategy was evaluated from the perspective of society and that of a third party payer.Results.From the perspective of society, the HA–CMC strategy had an overall cost per patient of $1932 and effectiveness of 7.901 QALYs and dominated the routine care strategy, which had a cost per patient of $3043 and effectiveness of 7.805 QALYs. From the perspective of a third party payer, the HA–CMC strategy had an overall cost per patient of $1247 and effectiveness of 7.987 QALYs and dominated the routine care strategy, which had a cost per patient of $1629 and effectiveness of 7.970 QALYs. A series of one-way sensitivity analyses confirmed the robustness of the model.Conclusions.Under a conservative set of clinical and economic assumptions, an adhesion prevention strategy utilizing a HA–CMC barrier in patients undergoing radical hysterectomy for Stage IB cervical cancer is cost-effective from both the perspective of society as a whole and that of a third party payer.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Gynecologic Oncology - Volume 104, Issue 3, March 2007, Pages 739–746
نویسندگان
, , , , , ,